Names and pronunciation
(e-tel-kal′-se-tide) Parsabiv
PDF page 525
Drug reference
(e-tel-kal′-se-tide) Parsabiv
PDF page 525
Func. class.: Parathyroid analog
PDF page 525
USES: For the treatment of secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis
PDF page 525
DOSAGE AND ROUTES Secondary hyperparathyroidism in patients with chronic kidney dis- ease on hemodialysis • Adult: IV 5 mg 3×/wk at the end of he- modialysis treatment, max 15 mg 3×/wk For patients switching from cina- calcet to etelcalcetide • Adult: IV: 5 mg 3×/wk at the end of hemodialysis treatment after discontinu- ing cinacalcet for at least 7 days
PDF page 525
Available forms: Injection 2.5 mg/0.5 mL, 5 mg/mL, 10 mg/2 mL single dose
PDF page 525
• Adult: IV 5 mg 3×/wk at the end of he- modialysis treatment, max 15 mg 3×/wk For patients switching from cina- calcet to etelcalcetide
PDF page 525
• Adult: IV: 5 mg 3×/wk at the end of hemodialysis treatment after discontinu- ing cinacalcet for at least 7 days
PDF page 525